SCHEMBL5178013

SCHEMBL5178013

S=C1Nc2ccccc2C(c2ccc(Cl)cc2)N1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.55
GAA P10253 2/20 0.55
PRCP P42785 1/20 0.43
ALDH1A1 P00352 6/20 0.43
KDM4E B2RXH2 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAPT P10636 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
GUSB P08236 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
ALOX12 P18054 1/20 0.42
MC4R P32245 1/20 0.42
CYP2C19 P33261 1/20 0.42
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9567855 0.86 ALDH1A1 (0.54) KMT2AGAAPRCPALDH1A1MAPT
SCHEMBL5176626 0.86 ALDH1A1 (0.54) KMT2AGAAPRCPALDH1A1MAPT
SCHEMBL5177579 0.81 ALDH1A1 (0.46) KMT2AGAAALDH1A1KDM4ESMN1; SMN2
SCHEMBL5205016 0.81 ALDH1A1 (0.46) KMT2AGAAALDH1A1KDM4EMAPT
SCHEMBL25141969 0.80 ALDH1A1 (0.39) KMT2AGAAALDH1A1KDM4EMAPT
SCHEMBL5696233 0.74 DHFR (0.54) KMT2AGAAALDH1A1KDM4EL3MBTL1
SCHEMBL5177430 0.74 MAPT (0.50) KMT2AGAAALDH1A1SMN1; SMN2MAPT
SCHEMBL5696272 0.72 CHRM1 (0.42) KMT2AGAAALDH1A1KDM4EMAPT
SCHEMBL5696249 0.71 DHFR (0.51) ALDH1A1SMN1; SMN2GUSBHTTTSHR
SCHEMBL5696173 0.70 DHFR (0.50) KMT2AALDH1A1SMN1; SMN2MAPTGUSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807402-A1 QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS ANTIMITOTICS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID DERIVATIVES EMBL (DE) 2007-07-18 EP disclosed
WO-2006048308-A1 QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS ANTIMITOTICS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID DERIVATIVES EMBL (DE) 2006-05-11 WO disclosed